Trials / Completed
CompletedNCT06227923
A Protected Discharge Model Using Technology in Multimorbid and Poly-treated Older Subjects
Development and Validation of a Protected Discharge Model Using Technology in Multimorbidity and Poly-treated Older Subjects. The PRO-HOME Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Alberto Pilotto · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The main goal of thi clinical trial is to evaluate if a protected discharge model can reduce the length of hospital stay in older participants aged over 65 years old who have been admitted to the hospital for an acute event and have been considered stable and dischargeable. Participants of the intervention group will be asked to transfer to a small apartment, inside the hospital setting, equipped by technological devices and to be involved in cognitive and physical activities during the stay. Researchers will compare this intervention group with a control group who receive normal clinical practice where older people remain in the hospital ward.
Detailed description
Participants who fit the inclusion criteria are randomized in two arms (intervention or control groups). All of them are evaluated with a comprehensive geriatric assessment (Multidimensional Prognostic Index), a depression scale (Geriatric Depression Scale), quality of Life scale (Short-Form 12 items), and physical parameters (Hand Grip, Short Physical Performance Battery, gait speed). In the intervention group the following clinical parameters will be collected through technological devices: spontaneous physical performance, sleep monitoring, gait speed, quality of movements, heart rate, SpO2, and other vital parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PRO-HOME intervention | Patients are transferred to the apartment inside the hospital setting and are evaluated and assessed also using technological devices |
Timeline
- Start date
- 2021-05-28
- Primary completion
- 2023-04-18
- Completion
- 2023-10-18
- First posted
- 2024-01-29
- Last updated
- 2024-01-29
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06227923. Inclusion in this directory is not an endorsement.